Left Atrial Appendage Closure (LAAC) is a minimally invasive procedure designed to reduce the risk of stroke in patients with atrial fibrillation (AFib). AFib, a common heart rhythm disorder, increases the likelihood of blood clots forming in the heart’s left atrial appendage (LAA). These clots can travel to the brain, causing a stroke. LAAC aims to seal off the LAA, preventing clots from escaping and reducing stroke risk in individuals who cannot take long-term blood thinners due to bleeding risks or other complications.
The Role of the Left Atrial Appendage (LAA) in Stroke Risk
The LAA is a small, ear-shaped sac located in the upper left chamber of the heart. While it serves no critical function, it is the primary source of blood clot formation in AFib patients. Because the heart does not pump efficiently during AFib episodes, blood can pool and clot in this area. When a clot breaks free, it can travel through the bloodstream to the brain, leading to a stroke.
How LAAC Works
The LAAC procedure involves placing a small device inside the LAA to permanently seal it off. This is typically done through a catheter inserted into a vein in the leg and guided to the heart. Once the device is positioned and expanded within the LAA, it blocks blood flow into the appendage, preventing clots from forming or escaping. Over time, heart tissue grows over the device, creating a natural seal.
Benefits of LAAC
LAAC offers several benefits, especially for patients who are not candidates for long-term anticoagulation therapy:
- Stroke Risk Reduction: By preventing clots from forming in the LAA, LAAC significantly lowers the risk of AFib-related strokes.
- No Need for Lifelong Blood Thinners: For patients at risk of bleeding or with contraindications to blood thinners, LAAC provides an alternative to reduce stroke risk without the complications of anticoagulation.
- Minimally Invasive: The procedure is minimally invasive, requiring only a small incision, and most patients can return to normal activities within a few days.
- Long-Term Protection: Once the LAA is sealed, patients are protected from future strokes related to clots from this area.
Who Should Consider LAAC?
LAAC is recommended for individuals with non-valvular atrial fibrillation who are at an increased risk of stroke and unable to take blood thinners long-term. Before deciding on LAAC, patients typically undergo a thorough evaluation by their cardiologist to assess the risks and benefits.
Common LAAC Devices
Several LAAC devices are available, including the Watchman device and the Amplatzer Amulet. These devices are FDA-approved and are effective in reducing stroke risk.
Risks and Considerations
While LAAC is a safe and effective procedure, it does carry some risks, including infection, device migration, and complications related to the catheter insertion. However, the procedure’s benefits often outweigh these risks, particularly for patients at high risk for stroke and bleeding.
« Back to Glossary Index